Target Selection & Selectivity Engineering in a 2+1 T-Cell Engager Format Can Drive Positive Clinical Outcomes

• How do target properties, affinity, and format interplay during early research?
• What molecular properties can lead to successful T-cell engager platforms at multiple levels of development?
• What opportunities are available upon initial positive clinical signals?

Speakers:

Alex Nisthal

Director, Protein Engineering

Xencor